Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial have?
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial has 221 citations in the OpenAlex counts ScholarIQ stores.
When was Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial published?
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial has 2022 year in the ScholarIQ index.
What is the open-access status of Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial?
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial has hybrid oa status in the ScholarIQ index.
What is the DOI of Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial?
The DOI for Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial is on the source record.
What is the PMID of Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial?
The PMID for Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial is on the source record.
What is the OpenAlex record for Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial?
The OpenAlex for Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial is on the source record.